Organigram Global Inc. (NASDAQ: OGI)

Organigram Global Inc. is a licensed cannabis cultivator and producer of consumer packaged goods containing cannabis. The company manufactures and distributes cannabis products to wholesale and retail channels in Canada exports to international jurisdictions and distributes hemp derived THC beverages and edibles in the United States. It operates five facilities across Canada including the Moncton Campus for indoor cultivation and manufacturing the Winnipeg Facility for ingestible products the Lac Superior Facility for hash concentrates and premium flower the Aylmer Facility for extraction and manufacturing and the London Facility for warehousing and distribution. As of the end of fiscal 2025 the company held the number one market share position in the Canadian recreational cannabis market.

The company generates revenue primarily from the sale of dried flower cannabis derivatives such as edibles vapes extracts and pre rolls to recreational and medical cannabis consumers wholesale distributors and international markets. Revenue also comes from the sale of hemp derived THC beverages and edibles in the United States. Sales are made through direct channels and through partnerships with retail operators and licensed distributors.

Organigram Global Inc. holds the leading position in the Canadian recreational cannabis market with the number one market share as of the end of fiscal 2025. The company competes with other licensed producers in Canada and internationally. Its competitive advantages stem from a fully integrated production network that includes cultivation extraction manufacturing and distribution capabilities. The company benefits from a strong innovation pipeline supported by its partnership with British American Tobacco and ongoing investments in facility automation and cannabis research. Additionally its focus on cost efficiency and scale helps improve margins and supports its ability to meet evolving consumer demand.

The company serves recreational cannabis consumers medical cannabis patients wholesale distributors and international business customers in countries such as Germany Australia and the United Kingdom. In the United States the company sells hemp derived THC beverages and edibles to adult use consumers through retail channels.